Un estudio encontró que la aspirina de dosis baja no afecta el riesgo de demencia en los pacientes con diabetes

Related Posts
U.S. to End Mpox Public Health Emergency in January
December 5, 2022
MONDAY, Dec. 5, 2022 (HealthDay News) – Mpox cases are down significantly in the...
Diabetes Could Speed Progression of Blood Cancer Myeloma
October 2, 2023
MONDAY, Oct. 2, 2023 (HealthDay News) -- Diabetes may accelerate the growth of a...
Remote Evaluation Feasible for Preoperative Bariatric Care
February 17, 2023
FRIDAY, Feb. 17, 2023 (HealthDay News) -- Fully remote preoperative bariatric...
Vaccination Plus Prior Infection Best Defense Against COVID
January 20, 2022
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Think your prior bout of COVID...
